Allogene Therapeutics, Inc. - ALLO

Latest data: 3/19/2026 10:04:25 PM
EDGAR CIK 0001737287

Buy Breakdown

Total $0

Sell Breakdown

Total $639,928

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
03/16/2026
03/18/2026
SVP, Chief Technical Officer
Officer
Sell
-4,835 @ $2.47
($11,942.45)
198,205 (-2.38%) Direct
03/16/2026
03/18/2026
President and CEO
CEO Director
Sell
-47,763 @ $2.47
($117,974.61)
5,150,599 (-0.92%) Direct
03/02/2026
03/04/2026
SVP, Chief Technical Officer
Officer
Sell
-7,132 @ $2.60
($18,543.20)
203,040 (-3.39%) Direct
02/02/2026
02/04/2026
SVP, Chief Technical Officer
Officer
Sell
-7,549 @ $1.73
($13,059.77)
210,172 (-3.47%) Direct
02/02/2026
02/04/2026
President and CEO
CEO Director
Sell
-95,269 @ $1.80
($171,484.20)
5,185,862 (-1.80%) Direct
02/02/2026
02/04/2026
SVP, General Counsel
Officer
Sell
-22,900 @ $1.76
($40,304.00)
564,948 (-3.90%) Direct
02/02/2026
02/04/2026
CHIEF FINANCIAL OFFICER
CFO
Sell
-24,001 @ $1.76
($42,241.76)
1,252,795 (-1.88%) Direct
02/02/2026
02/04/2026
EVP of R&D
Officer
Sell
-35,700 @ $1.77
($63,189.00)
581,166 (-5.79%) Direct
02/02/2026
02/04/2026
SVP, Finance
Officer
Sell
-4,167 @ $1.72
($7,167.24)
130,322 (-3.10%) Direct
01/21/2026
01/23/2026
EVP of R&D
Officer
Sell
-26,269 @ $1.56
($40,979.64)
616,866 (-4.08%) Direct
11/17/2025
11/19/2025
SVP, Chief Technical Officer
Officer
Sell
-786 @ $1.22
($958.92)
217,721 (-0.36%) Direct
10/21/2025
10/23/2025
CHIEF FINANCIAL OFFICER
CFO
Sell
-36,744 @ $1.26
($46,168.84)
1,276,796 (-2.80%) Direct
06/10/2025
10b5-1
06/12/2025
Director
Sell
-36,885 @ $1.42
($52,376.70)
107,431 (-25.56%) Direct
04/21/2025
04/23/2025
SVP, Finance
Officer
Sell
-9,601 @ $1.41
($13,537.41)
130,663 (-6.84%) Direct